A Randomized, Double Blind, Placebo Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Curene® versus Placebo in Reducing Symptoms of Knee OA.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/30498758
Conclusion of this study
The reduction from baseline in total WOMAC score (also subscale scores) and VAS score resulted in statistically significant difference when compared to placebo. It was also found to be safe and well tolerated as there was no incidence of treatment related AEs.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study